Daniel Yokom

Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2

Joyce C. Wu, Cathy Lee, Daniel Yokom et al. · Cancer Research · 2006 · 157 citations

Medicine, Molecular Biology, Oncology +17

The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor

Karen To, Yi Zhao, Helen Jiang et al. · Molecular Pharmacology · 2007 · 33 citations

Medicine, Molecular Biology, Oncology +17

Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer

Daniel Yokom, Shabbir M.H. Alibhai, Schroder Sattar et al. · Journal of Geriatric Oncology · 2018 · 28 citations

Medicine, Geriatric Medicine, Oncology +17

Beyond the black box of geriatric assessment: Understanding enhancements to care by the geriatric oncology clinic

Shabbir M.H. Alibhai, Rana Jin, Allison Loucks et al. · Journal of Geriatric Oncology · 2018 · 28 citations

Medicine, Geriatric Medicine, Oncology +17

Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel

Daniel Yokom, John A. Stewart, Nimira Alimohamed et al. · Canadian Urological Association Journal · 2018 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17